Association between hypertensive disorders of pregnancy and new cardiovascular diseases within 24 months postpartum

Short and long-term complications of hypertensive disorders of pregnancy: lifelong cardiovascular risks we cannot ignore

“…Abnormal left ventricular remodeling with higher left ventricular mass, increased left ventricular wall thickness, and lower global longitudinal strain has been demonstrated as early as 3 months postpartum in patients with HDP and subsequent CHTN diagnosis [31]. Heart failure and CVA are more prevalent in the two years following a HDP, which is largely driven by the persistence of chronic hypertension during that timeframe [33 ▪ ]. HDP patients have a higher incidence of other CVD risk factors including diabetes mellitus, dyslipidemia, and metabolic syndrome [21 ▪▪ ].…”

Cardiovascular mortality in the context of hypertensive disorders of pregnancy: Towards an optimisation of case identification strategies

“…This raises concerns regarding the utility of data sources that capture events based on calendar year, since the postpartum period is known to be a high-risk period for mortality for individuals with HDP and cardiovascular complications. 9 However, the increased risk in the earlier periods of follow-up (<60 days postpartum) suggests that the extent of the attenuation of the observed associations may be less of a concern. While, Lee and colleagues 3 demonstrated the added value of conducting maternal mortality surveillance using routine administrative datasets with extended follow-up beyond 42 days postpartum, the results need to be interpreted in light of the potential limitations arising from the quality of the data source.…”

“…Finally, due to the process for data collection in the NRD, the ability to observe events up to 1 year postpartum was not possible for all women delivering after January, resulting in missed events. This raises concerns regarding the utility of data sources that capture events based on calendar year, since the postpartum period is known to be a high‐risk period for mortality for individuals with HDP and cardiovascular complications 9 . However, the increased risk in the earlier periods of follow‐up (<60 days postpartum) suggests that the extent of the attenuation of the observed associations may be less of a concern.…”